154 related articles for article (PubMed ID: 15481451)
1. Successful allogeneic bone marrow transplantation in a patient with acute myelogenous leukemia and cytomegalovirus retinitis.
Matsubara H; Adachi S; Yano J; Kitamura N; Miyazaki M; Mizushima Y; Hiramatsu H; Kobayashi M; Nakahata T
Int J Hematol; 2004 Aug; 80(2):190-2. PubMed ID: 15481451
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab.
Song WK; Min YH; Kim YR; Lee SC
Ophthalmology; 2008 Oct; 115(10):1766-70. PubMed ID: 18562004
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient.
Okamoto T; Okada M; Mori A; Saheki K; Takatsuka H; Wada H; Tamura A; Fujimori Y; Takemoto Y; Kanamaru A; Kakishita E
Bone Marrow Transplant; 1997 Nov; 20(9):801-3. PubMed ID: 9384487
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus retinitis diagnosed after completion of chemotherapy for acute lymphoblastic leukemia in an adolescent.
Han SB; Lee JH; Lee JW; Chung NG; Cho B; Kang JH; Kim HK; Lee JH; Lee WK
J Pediatr Hematol Oncol; 2015 Mar; 37(2):e128-30. PubMed ID: 25222055
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus retinitis in children and adolescents with acute leukemia following allogeneic hematopoietic stem cell transplantation.
Zöllner SK; Herbrüggen H; Kolve H; Mihailovic N; Schubert F; Reicherts C; Rössig C; Groll AH
Transpl Infect Dis; 2019 Oct; 21(5):e13089. PubMed ID: 30972869
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus Retinitis in an ALL child on exclusive chemotherapy treated successfully with intravitreal ganciclovir alone.
Singh R; Singh R; Trehan A; Jain R; Bhalekar S
J Pediatr Hematol Oncol; 2013 Apr; 35(3):e118-9. PubMed ID: 23042013
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of CMV retinitis with ganciclovir after allogeneic marrow transplantation.
Kaulfersch W; Urban C; Hauer C; Lackner H; Gamillscheg A; Slavc I; Langmann G
Bone Marrow Transplant; 1989 Sep; 4(5):587-9. PubMed ID: 2551437
[TBL] [Abstract][Full Text] [Related]
8. CMV retinitis after cessation of ganciclovir therapy for CMV antigenemia in an unrelated BMT recipient.
Suzuki N; Kudoh T; Mizue N; Watanabe J; Ikehata M; Tateno M; Ooguro H; Chiba S
Bone Marrow Transplant; 1998 Nov; 22(9):931-2. PubMed ID: 9827825
[TBL] [Abstract][Full Text] [Related]
9. Use of the ganciclovir implant for treating cytomegalovirus retinitis secondary to immunosuppression after bone marrow transplantation.
McAuliffe PF; Hall MJ; Castro-Malaspina H; Heinemann MH
Am J Ophthalmol; 1997 May; 123(5):702-3. PubMed ID: 9152083
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation following busulfan and 90 mg/kg of cyclophosphamide.
Avalos BR; Klein JL; Kapoor N; Copelan EA
Bone Marrow Transplant; 1993 Dec; 12(6):655-8. PubMed ID: 8136749
[TBL] [Abstract][Full Text] [Related]
11. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
12. Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.
Emminger W; Emminger-Schmidmeier W; Haas OA; Urban C; Ambros P; Peters C; Mann G; Fink FM; Ferstl G; Höcker P
Bone Marrow Transplant; 1992 May; 9(5):313-8. PubMed ID: 1617314
[TBL] [Abstract][Full Text] [Related]
13. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus retinitis in a patient with secondary acute lymphosarcoma leukemia undergoing allogeneic hematopoietic stem-cell transplantation: A rare case report: a care-compliant article.
Zhao N; Liu L; Xu J
Medicine (Baltimore); 2017 May; 96(19):e6878. PubMed ID: 28489788
[TBL] [Abstract][Full Text] [Related]
15. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
[TBL] [Abstract][Full Text] [Related]
16. Busulfan/cyclophosphamide plus bone marrow transplantation is not sufficient to eradicate the malignant clone in juvenile chronic myelogenous leukemia.
Urban C; Schwinger W; Slavc I; Schmid C; Gamillscheg A; Lackner H; Hauer C; Pakisch B
Bone Marrow Transplant; 1990 May; 5(5):353-6. PubMed ID: 2190661
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
Matsuyama T; Kojima S; Kato K
Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
[TBL] [Abstract][Full Text] [Related]
18. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
Crippa F; Corey L; Chuang EL; Sale G; Boeckh M
Clin Infect Dis; 2001 Jan; 32(2):214-9. PubMed ID: 11170910
[TBL] [Abstract][Full Text] [Related]
19. [Second marrow transplantation following high dose busulfan, etoposide, and Ara-C after testicular relapse in a patient with AML].
Matsue K; Tohi T; Masauji N; Tsukuda K
Rinsho Ketsueki; 1992 Mar; 33(3):338-42. PubMed ID: 1578638
[TBL] [Abstract][Full Text] [Related]
20. Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation for non-A, non-B, non-C hepatitis.
Hägglund H; Winiarski J; Ringdén O; Sparrelid E; Ericzon BG
Transplantation; 1997 Oct; 64(8):1207-8. PubMed ID: 9355843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
